K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · RVTY
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-23 | RVTY | REVVITY INC. | REVVITY, INC. | $35K | Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act Support for Genetic Screening Proposals related to pandemic preparedness |
| 2026-01-09 | RVTY | REVVITY INC. | REVVITY, INC. | $30K | Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs |
| 2025-10-02 | RVTY | REVVITY INC. | REVVITY, INC. | $30K | Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs Medical Device & Pharmaceutical Adjacent Tariff |
| 2025-04-24 | RVTY | REVVITY INC. | REVVITY, INC. | $30K | Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariff |
| 2025-04-24 | RVTY | REVVITY INC. | REVVITY, INC. | $0 | SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T |
| 2025-04-07 | RVTY | REVVITY INC. (FORMERLY PERKINELMER INC.) | REVVITY, INC. (FORMERLY PERKINELMER, INC.) | $70K | Diagnostic test reimbursement and policies; Proposals related to newborn screening; Proposals related to pandemic preparedness; H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses |